These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32346420)

  • 1. CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner.
    Niu Y; Tang D; Fan L; Gao W; Lin H
    Exp Ther Med; 2020 Jun; 19(6):3571-3580. PubMed ID: 32346420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
    Lu L; Du H; Huang H; Wang C; Wang P; Zha Z; Wu Y; Liu X; Weng C; Fang X; Li B; Mao H; Wang L; Guan M; Liu G
    Int J Med Sci; 2020; 17(7):912-920. PubMed ID: 32308544
    [No Abstract]   [Full Text] [Related]  

  • 4. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
    Johnson-Holiday C; Singh R; Johnson E; Singh S; Stockard CR; Grizzle WE; Lillard JW
    Int J Oncol; 2011 May; 38(5):1279-85. PubMed ID: 21344163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
    Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
    Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
    Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis.
    Gupta P; Sharma PK; Mir H; Singh R; Singh N; Kloecker GH; Lillard JW; Singh S
    Oncotarget; 2014 Oct; 5(20):10170-9. PubMed ID: 25296976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
    Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
    Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.
    Amersi FF; Terando AM; Goto Y; Scolyer RA; Thompson JF; Tran AN; Faries MB; Morton DL; Hoon DS
    Clin Cancer Res; 2008 Feb; 14(3):638-45. PubMed ID: 18245522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
    Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
    Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the contribution of single nucleotide polymorphisms in
    Airaksinen L; Cerqueira JX; Huhtala H; Saavalainen P; Yohannes DA; Mäki M; Kurppa K; Kilpeläinen E; Shcherban A; Palotie A; Kaukinen K; Lindfors K
    J Transl Autoimmun; 2021; 4():100128. PubMed ID: 34901814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells.
    Heinrich EL; Arrington AK; Ko ME; Luu C; Lee W; Lu J; Kim J
    Cancer Microenviron; 2013 Dec; 6(3):241-5. PubMed ID: 23371851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.
    Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R
    DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR9 and CCL25: A review of their roles in tumor promotion.
    Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
    J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
    Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
    Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
    Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular expression profile and clinical significance of the CCR9-CCL25 chemokine receptor complex in nasopharyngeal carcinoma.
    Ye LF; Huang J; Zhang LP; Chen Z
    J Laryngol Otol; 2015 Oct; 129(10):1013-9. PubMed ID: 26279399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
    Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
    Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25.
    Uehara S; Song K; Farber JM; Love PE
    J Immunol; 2002 Jan; 168(1):134-42. PubMed ID: 11751956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP3 facilitates the invasion and metastasis of non-small cell lung cancer cells through regulating VEGF, EMT and the Notch1/Hes1 pathway.
    Li C; Wang H; Fang H; He C; Pei Y; Gai X
    Exp Ther Med; 2021 Sep; 22(3):958. PubMed ID: 34335900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.